Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XXIA
1326
DELISTED
Ixia
XXIA
| $5.6M | 0.01% |
449,964
-141,550
| -24% | -$1.76M |
|
1327
Amkor Technology
AMKR
$12.1B
| $5.6M | 0.01% |
935,826
-308,520
| -25% | -$2.22M |
|
1328
UDR
UDR
$12.3B
| $5.59M | 0.01% |
+174,430
| New | +$5.73M |
|
1329
Terreno Realty
TRNO
$7.45B
| $5.58M | 0.01% |
283,178
+130,950
| +86% | +$2.77M |
|
1330
PUT
Exelixis
EXEL
$14.1B
| $5.57M | 0.01% |
1,481,400
+1,466,100
| +9,582% | +$4.77M |
|
|
ARIA
1331
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $5.57M | 0.01% |
673,253
-971,700
| -59% | -$8.59M |
|
1332
Pearson
PSO
$9.98B
| $5.56M | 0.01% |
293,271
+168,612
| +135% | +$3.44M |
|
|
GRFS
1333
CALL
Grifois
GRFS
$5.51B
| $5.56M | 0.01% |
+400,000
| New | +$6.49M |
|
1334
CALL
Emerson Electric
EMR
$86.4B
| $5.54M | 0.01% |
+100,000
| New | +$5.88M |
|
|
RPRX
1335
DELISTED
Repros Therapeutics Inc.
RPRX
| $5.51M | 0.01% |
770,676
+99,519
| +15% | +$775K |
|
|
CVRR
1336
CALL
DELISTED
CVR Refining, LP
CVRR
| $5.5M | 0.01% |
+300,400
| New | +$6.04M |
|
1337
New Oriental
EDU
$9.08B
| $5.49M | 0.01% |
224,012
+186,758
| +501% | +$4.63M |
|
|
CLNY
1338
DELISTED
Colony Capital, Inc.
CLNY
| $5.46M | 0.01% |
241,195
-414,250
| -63% | -$10.5M |
|
1339
Stryker
SYK
$127B
| $5.46M | 0.01% |
57,095
-104,969
| -65% | -$9.95M |
|
|
JBTM
1340
JBT Marel
JBTM
$6.12B
| $5.45M | 0.01% |
145,002
+83,336
| +135% | +$3.07M |
|
1341
Advanced Energy
AEIS
$11B
| $5.45M | 0.01% |
198,207
+70,786
| +56% | +$1.92M |
|
|
DRNA
1342
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.45M | 0.01% |
+390,464
| New | +$7.16M |
|
|
IMPR
1343
DELISTED
IMPRIVATA, INC COM
IMPR
| $5.45M | 0.01% |
332,798
+117,525
| +55% | +$1.76M |
|
1344
Viasat
VSAT
$9.98B
| $5.44M | 0.01% |
90,209
-218,548
| -71% | -$13.6M |
|
|
CWEN.A
1345
DELISTED
Clearway Energy Class A
CWEN.A
| $5.43M | 0.01% |
+246,870
| New | +$6.06M |
|
|
SYKE
1346
DELISTED
SYKES Enterprises Inc
SYKE
| $5.43M | 0.01% |
223,783
+87
| +0% | +$2.15K |
|
1347
Employers Holdings
EIG
$876M
| $5.42M | 0.01% |
237,725
-37,967
| -14% | -$929K |
|
1348
American Eagle Outfitters
AEO
$2.8B
| $5.41M | 0.01% |
314,355
-3,852,230
| -92% | -$64.8M |
|
|
MCRL
1349
DELISTED
MICREL INC
MCRL
| $5.41M | 0.01% |
389,012
+321,466
| +476% | +$4.53M |
|
|
CBPO
1350
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $5.39M | 0.01% |
+46,797
| New | +$4.92M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.